Votruba Michal 4
4 · BioXcel Therapeutics, Inc. · Filed May 23, 2022
Insider Transaction Report
Form 4
Votruba Michal
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-19+17,000→ 17,000 totalExercise: $13.24Exp: 2032-05-19→ Common Stock (17,000 underlying) - Other
Stock Option (Right to Buy)
2022-05-19−17,000→ 0 totalExercise: $13.24Exp: 2032-05-19→ Common Stock (17,000 underlying)
Footnotes (2)
- [F1]The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund ("RSJ") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person does not beneficially own any of the securities reported herein.
- [F2]The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date.